A groundbreaking study from Penn Medicine reveals that psilocybin may effectively alleviate chronic pain and improve mental health by targeting specific brain circuits. This research opens new avenues for non-addictive therapies.
KJ Muldoon, born with a deadly genetic disorder, received a groundbreaking CRISPR treatment just six months after birth. His remarkable progress showcases the future of personalized medicine for rare diseases.
